Manufacturer record
Supercure Biotech Pvt. Ltd: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
5 batches manufactured by Supercure Biotech Pvt. Ltd (Haryana) were declared Not of Standard Quality between December 2021 and July 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
5 records linked to Supercure Biotech Pvt. Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Paracetamol, Phenylephrine HCL, Guaiphenesin, Cetirizine Hydrochloride & Ambroxol HCL Tablets | SBT-3351Mfg 2025-07 · Exp 2027-06 | The sample is found to be Not of Standard Quality for the reason stated under Description.Description | CDL, KolkataCDSCO lab | Jul 2026 |
| Loperamide Hydrochloride Capsules I.P | C-2127Mfg 2024-12 · Exp 2026-11 | Dissolution TestDissolution | DTL, Bengaluru, KarnatakaState lab | Apr 2026 |
| ROSE-4 DSR | C2269Mfg 2025-01 · Exp 2026-12 | content of RabeprazoleOther | Uttar PradeshState lab | Jan 2026 |
| Pantoprazole Sodium Gastro-resistant & Domperidone Prolonged Release Capsule IP | C-1594Mfg 2024-02 · Exp 2026-01 | Assay of DomperidoneAssay | Uttar PradeshState lab | Jan 2026 |
| Omeprazole Capsule I.P. 20 mg. | SBC-20/021Mfg 2020-03 · Exp 2022-02 | DissolutionDissolution | RDTL GuwahatiState lab | Dec 2021 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.